California 20252026 Regular Session Status: Passed Senate 1 R cosponsors

SR 118 — Relative to Prostate Cancer Awareness Month.

Last action — Read. Adopted. (Ayes 35. Noes 0.)

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed Assembly
  5. 5
    To Executive
  6. 6
    Enacted

This bill has passed the Senate. Introduced June 11, 2026. It now moves to the second chamber.

Next likely step: consideration and a floor vote in the Assembly.

Prognosis

Advancing 48% · moderate confidence

Where this bill stands today.

Odds of enactment

High

How often bills like it became law.

  • Passed Senate

    Current position in the legislative process.

  • 1 sponsor

    1 primary, 0 co-sponsors signed on.

  • Single-party support

    Sponsorship is currently within one party (1 R).

  • Cleared a recorded vote

    Passed 1 recorded vote so far.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

In plain language

The bill establishes a month dedicated to prostate cancer awareness.

This legislation designates a specific month each year for raising awareness about prostate cancer. It aims to educate the public and encourage early detection.

Bill Text

What changed in the latest version

1 added · 1 removed

Plain-language change summary

The latest version of SR 118 has added some specific language that clarifies the bill's intent. In the previous version, certain sections were vague, making it hard to understand the bill's purpose. This change is important because it helps ensure that everyone knows exactly what the bill aims to achieve, which can lead to better support and implementation.

→
Previous
Latest
Bill Text - SR-118 skip to content home accessibility FAQ feedback sitemap login x Quick Search:
20250SR__011898ENR 98 INTRODUCED 2026-06-11 PASSED_SENATE 2026-08-06 ENROLLED 2026-08-07 2025 0 SR 118 ENR Introduced by Senator Niello LEAD_AUTHOR SENATE Niello Relative to Prostate Cancer Awareness Month.
Bill Number Bill Keyword Home Bill Information California Law Publications Other Resources My Subscriptions My Favorites Bill Information >> Bill Search >> Text Bill Text PDF2 Bill PDF |Add To My Favorites |Track Bill | Version:
Prostate Cancer Awareness Month WHEREAS, Prostate cancer is the most commonly diagnosed nonskin cancer and the second leading cause of cancer-related deaths among men in the United States;
08/07/26 - Enrolled 06/11/26 - Introduced SR-118 (2025-2026) Text >> Votes >> History >> Bill Analysis >> Today's Law As Amended >> Compare Versions >> Status >> Comments To Author >> Track Bill >> Add To My Favorites >> SHARE THIS:
and WHEREAS, Approximately 333,830 men in the United States will be diagnosed with prostate cancer in 2026, and approximately 36,320 men will die from the disease, equating to one death every 15 minutes;
SR118:v98#DOCUMENTBill Start Enrolled  August 07, 2026 Passed  IN  Senate  August 06, 2026 CALIFORNIA LEGISLATURE— 2025–2026 REGULAR SESSION Senate Resolution No.
and WHEREAS, More than 3,300,000 men in the United States are currently living with prostate cancer;
118Introduced by Senator NielloJune 11, 2026 Relative to Prostate Cancer Awareness Month.
and WHEREAS, One in 8 men will be diagnosed with prostate cancer during their lifetime, and 1 in 41 will die from the disease;
LEGISLATIVE COUNSEL'S DIGESTSR 118, Niello.
and WHEREAS, African American men face disproportionately higher risks, with approximately one in six diagnosed and mortality rates nearly twice that of other populations;
Digest KeyBill TextWHEREAS, Prostate cancer is the most commonly diagnosed nonskin cancer and the second leading cause of cancer-related deaths among men in the United States;
and WHEREAS, The risk of prostate cancer increases significantly after 50 years of age and is higher among individuals with a family history of the disease;
andWHEREAS, Approximately 333,830 men in the United States will be diagnosed with prostate cancer in 2026, and approximately 36,320 men will die from the disease, equating to one death every 15 minutes;
and WHEREAS, Prostate cancer often presents no noticeable symptoms in its early stages, making early detection through appropriate screening critically important;
andWHEREAS, More than 3,300,000 men in the United States are currently living with prostate cancer;
and WHEREAS, Screening methods, including prostate-specific antigen blood tests and digital rectal examinations, may detect prostate cancer at an early and more treatable stage;
andWHEREAS, One in 8 men will be diagnosed with prostate cancer during their lifetime, and 1 in 41 will die from the disease;
and WHEREAS, When detected early, the survival rate for localized and regional prostate cancer approaches nearly 100 percent, while survival rates drop significantly once the cancer has metastasized;
andWHEREAS, African American men face disproportionately higher risks, with approximately one in six diagnosed and mortality rates nearly twice that of other populations;
and WHEREAS, Recent trends indicate that prostate cancer screening and routine testing may decline or be discontinued for some patients without adequate consultation or understanding of the associated risks;
andWHEREAS, The risk of prostate cancer increases significantly after 50 years of age and is higher among individuals with a family history of the disease;
and WHEREAS, It is essential that patients are aware of any changes to recommended testing practices and are empowered to make informed decisions about their health;
andWHEREAS, Prostate cancer often presents no noticeable symptoms in its early stages, making early detection through appropriate screening critically important;
and WHEREAS, Individuals are strongly encouraged to speak with their physicians to understand their personal risk factors, the benefits and risks of screening, and whether continued testing is appropriate for them;
andWHEREAS, Screening methods, including prostate-specific antigen blood tests and digital rectal examinations, may detect prostate cancer at an early and more treatable stage;
and WHEREAS, Increasing public awareness, education, and proactive communication between patients and health care providers can save lives and protect families;
andWHEREAS, When detected early, the survival rate for localized and regional prostate cancer approaches nearly 100 percent, while survival rates drop significantly once the cancer has metastasized;
now, therefore, be it Resolved by the Senate of the State of California, That the Senate hereby designates September 2026 as Prostate Cancer Awareness Month in California;
andWHEREAS, Recent trends indicate that prostate cancer screening and routine testing may decline or be discontinued for some patients without adequate consultation or understanding of the associated risks;
and be it further Resolved, That the Senate encourages all individuals, particularly those at higher risk, to engage in informed discussions with their health care providers regarding prostate cancer screening and early detection;
andWHEREAS, It is essential that patients are aware of any changes to recommended testing practices and are empowered to make informed decisions about their health;
and be it further Resolved, That the Senate urges increased awareness of the importance of continued vigilance in prostate cancer testing;
andWHEREAS, Individuals are strongly encouraged to speak with their physicians to understand their personal risk factors, the benefits and risks of screening, and whether continued testing is appropriate for them;
and be it further Resolved, That the Secretary of the Senate transmit copies of this resolution to the author for appropriate distribution.
andWHEREAS, Increasing public awareness, education, and proactive communication between patients and health care providers can save lives and protect families;
now, therefore, be itResolved by the Senate of the State of California, That the Senate hereby designates September 2026 as Prostate Cancer Awareness Month in California;
and be it furtherResolved, That the Senate encourages all individuals, particularly those at higher risk, to engage in informed discussions with their health care providers regarding prostate cancer screening and early detection;
and be it furtherResolved, That the Senate urges increased awareness of the importance of continued vigilance in prostate cancer testing;
and be it furtherResolved, That the Secretary of the Senate transmit copies of this resolution to the author for appropriate distribution.
View plain text versions (3)

Action History

  1. Read. Adopted. (Ayes 35. Noes 0.)

  2. Ordered to special consent calendar.

  3. From committee: Ordered to third reading.

  4. Introduced. Referred to Com. on RLS.

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 121 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (121)

121 members have not signed on to this bill.

Show all 121 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

Passed 35 Yea · 0 Nay · 5 Other
Party YeaNayPresentNot Voting
Unaffiliated 5001
Republican 6003
Democratic 24001
Total 35005
% of votes cast 88%0%0%13%
How each member voted (40)
Member Party Vote
Allen — Yea
Gonzalez — Yea
Ochoa Bogh — Yea
Pérez — Yea
Rubio — Yea
Weber Pierson — Not Voting
Archuleta, Bob Democratic Yea
Arreguín, Jesse Democratic Yea
Ashby, Angelique V. Democratic Yea
Becker, Josh Democratic Yea
Blakespear, Catherine S. Democratic Yea
Cabaldon, Christopher Democratic Yea
Caballero, Anna M. Democratic Yea
Cervantes, Sabrina Democratic Yea
Cortese, Dave Democratic Yea
Durazo, Maria Elena Democratic Yea
Grayson, Timothy S. Democratic Yea
Hurtado, Melissa Democratic Yea
Laird, John Democratic Yea
Limón, Monique Democratic Yea
McGuire, Mike Democratic Yea
McNerney, Jerry Democratic Yea
Menjivar, Caroline Democratic Yea
Padilla, Stephen C. Democratic Yea
Reyes, Eloise Gómez Democratic Not Voting
Richardson, Laura Democratic Yea
Smallwood-Cuevas, Lola Democratic Yea
Stern, Henry I. Democratic Yea
Umberg, Thomas J. Democratic Yea
Wahab, Aisha Democratic Yea
Wiener, Scott D. Democratic Yea
Alvarado-Gil, Marie Republican Not Voting
Choi, Steven S. Republican Yea
Dahle, Megan Republican Not Voting
Grove, Shannon Republican Yea
Jones, Brian W. Republican Yea
Niello, Roger W. Republican Yea
Seyarto, Kelly Republican Not Voting
Strickland, Tony Republican Yea
Valladares, Suzette Martinez Republican Yea

Official roll call →

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors SR 118?
SR 118 is sponsored by Niello, Roger W. (Republican).
What is the current status of SR 118?
This bill has passed the Senate. Introduced June 11, 2026. It now moves to the second chamber.
Where can I track SR 118?
Track SR 118 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SR 118

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of SR 118

Last checked for changes 2 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →